Inhalable nanovaccine with biomimetic coronavirus structure to trigger mucosal immunity of respiratory tract against COVID-19

The COVID-19 pandemic caused by SARS-CoV-2 seriously threatens global public health. It has previously been confirmed that SARS-CoV-2 is mainly transmitted between people through “respiratory droplets”. Therefore, the respiratory tract mucosa is the first barrier to prevent virus invasion. It is ver...

Descripción completa

Detalles Bibliográficos
Autores principales: Zheng, Bin, Peng, Wenchang, Guo, Mingming, Huang, Mengqian, Gu, Yuxuan, Wang, Tao, Ni, Guangjian, Ming, Dong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier B.V. 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7972832/
https://www.ncbi.nlm.nih.gov/pubmed/33762883
http://dx.doi.org/10.1016/j.cej.2021.129392

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7972832/
https://www.ncbi.nlm.nih.gov/pubmed/33762883
http://dx.doi.org/10.1016/j.cej.2021.129392

Ejemplares similares